CorMedix (CRMD) Revenue (2013 - 2026)
CorMedix (CRMD) posted Revenue of $128.6 million for Q4 2025, up 23.34% sequentially from $104.3 million in Q3 2025, and up 312.1% YoY from $31.2 million in Q4 2024.
CorMedix (CRMD) Revenue (2013 - 2026) Analysis & Trends
CorMedix has reported Revenue for 12 years, with the latest figure at $128.6 million in Q4 2025.
- Quarterly Revenue rose 312.1% year-over-year to $128.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $311.7 million (up 616.54% YoY) and the FY2025 annual result came in at $311.7 million, up 617.03% from the prior year.
- Revenue advanced to $128.6 million in Q4 2025 per CRMD's latest filing, from $104.3 million in the prior quarter.
- Over five years, Revenue peaked at $128.6 million in Q4 2025 and troughed at $6817.0 in Q3 2022.
- A 4-year average of $23.7 million and a median of $88261.0 in 2021 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2025: Revenue tumbled 91.35% in 2022, then jumped 4829.4% in 2025.
- Over 4 years, Revenue stood at $56397.0 in 2021, then sank by 47.33% to $29702.0 in 2022, then jumped by 104976.31% to $31.2 million in 2024, then surged by 312.1% to $128.6 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $128.6 million, $104.3 million, and $39.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | CorMedix | 644.42 Mn | 387.73 Mn | 77.13 Mn | 101.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.93 Mn |
| Dec 31, 2025 | 128.62 Mn |
| Sep 30, 2025 | 104.28 Mn |
| Jun 30, 2025 | 39.74 Mn |
| Mar 31, 2025 | 39.08 Mn |
| Dec 31, 2024 | 31.21 Mn |
| Sep 30, 2024 | 11.46 Mn |
| Jun 30, 2024 | 806,119.00 |
| Dec 31, 2022 | 29,702.00 |
| Sep 30, 2022 | 6,817.00 |
| Jun 30, 2022 | 21,253.00 |
| Mar 31, 2022 | 7,636.00 |
| Dec 31, 2021 | 56,397.00 |
| Sep 30, 2021 | 38,088.00 |
| Jun 30, 2021 | 8,191.00 |
| Mar 31, 2021 | 88,261.00 |
| Dec 31, 2020 | 55,714.00 |
| Sep 30, 2020 | 93,020.00 |
| Jun 30, 2020 | 16,443.00 |
| Mar 31, 2020 | 74,054.00 |